ORPHENGESIC FORTE

Post-LOE

orphenadrine citrate, aspirin and caffeine

ANDAORALTABLET
Approved
May 1998
Lifecycle
Post-LOE
Competitive Pressure
30/100

Mechanism of Action

Cyclooxygenase Inhibitors

Pharmacologic Class:

Nonsteroidal Anti-inflammatory Drug